Document Detail


Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease.
MedLine Citation:
PMID:  15900566     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Interleukin 6 (IL-6) may represent an early marker of inflammatory activation and may be useful to ameliorate risk stratification in patients with ischemic heart disease. The aim of this study was to verify the performance characteristics of an ultrasensitive immunoassay (Biosource International, Camarillo, CA) for high-sensitivity (hs)-IL-6 measurement in comparison with hs-R&D Systems (Abingdon, United Kingdom) and Immulite System (Diagnostic Products Corporation [DPC], Los Angeles, CA) methods in patients with ischemic heart disease. In addition, hs-C-reactive protein (hs-CRP) concentrations were measured, to evaluate the correlation with hs-IL-6 levels. We measured IL-6 and CRP serum levels in 39 patients with ischemic heart disease and in 12 controls. Out of the 39 patients studied, 13 were affected by unstable angina, 13 by post-acute myocardial infarction (AMI) unstable angina, and 13 by stable angina. The imprecision profile and functional sensitivity were performed measuring 9 different serum pools in 10 runs. The Biosource method had the best performance characteristics as compared to the others. Mean IL-6 level was higher in patients with unstable and post-AMI unstable angina with respect to controls. CRP levels were elevated in patients with post-AMI. In the whole population a high significant linear regression was observed between Biosource hs-IL-6 and hs-CRP serum levels. The Biosource method for IL-6 measurement is characterized by a high functional sensitivity that allows a better stratification of patients with ischemic heart disease.
Authors:
Valter Lubrano; Franca Cocci; Debora Battaglia; Angela Papa; Paolo Marraccini; Gian Carlo Zucchelli
Related Documents :
18711296 - Chronic inflammation increases risk in hemodialysis patients.
16425266 - Analysis of biologic surrogate markers from a children's oncology group phase i trial o...
10858406 - Preoperative and postoperative endotoxemia in children with congenital heart disease.
17497476 - The evaluation of effects of demographic features, biochemical parameters, and cytokine...
18229666 - Antioxidant activity of blood serum and saliva in patients with periodontal disease tre...
22144666 - Prognostic significance of prevalent and incident atrial fibrillation among patients ho...
Publication Detail:
Type:  Comparative Study; Evaluation Studies; Journal Article    
Journal Detail:
Title:  Journal of clinical laboratory analysis     Volume:  19     ISSN:  0887-8013     ISO Abbreviation:  J. Clin. Lab. Anal.     Publication Date:  2005  
Date Detail:
Created Date:  2005-05-24     Completed Date:  2005-08-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8801384     Medline TA:  J Clin Lab Anal     Country:  United States    
Other Details:
Languages:  eng     Pagination:  110-4     Citation Subset:  IM    
Copyright Information:
Copyright 2005 Wiley-Liss, Inc.
Affiliation:
Institute of Clinical Physiology, CNR, Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Angina, Unstable / diagnosis*
Biological Markers / blood
C-Reactive Protein / analysis
Coronary Artery Disease / diagnosis*
Female
Humans
Immunoassay / methods*
Interleukin-6 / blood*
Male
Middle Aged
Prognosis
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Interleukin-6; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sinonasal acinic cell carcinoma: a clinicopathologic study of four cases.
Next Document:  Hen egg immunoglobulin Y in colloidal gold agglutination assay: comparison with rabbit immunoglobuli...